BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 5496498)

  • 1. Separation of blood coagulation factors II, VII, IX and X by gel filtration in the presence of dextran blue.
    Swart AC; Hemker HC
    Biochim Biophys Acta; 1970 Dec; 222(3):692-5. PubMed ID: 5496498
    [No Abstract]   [Full Text] [Related]  

  • 2. Gel filtration properties of factors II, VII, IX, IX a , and X.
    Osterud B; Schiffman S
    Thromb Diath Haemorrh; 1972 Oct; 28(2):317-24. PubMed ID: 4629507
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the prothrombin complex, II. Behavior of prothrombin, factor VII, IX and X during column chromatography on anion exchangesRS].
    Voss D
    Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1172-8. PubMed ID: 5588277
    [No Abstract]   [Full Text] [Related]  

  • 4. Chromatography of human plasma on aminohexyl Sepharose: separation of factor VIII/vWf and behaviour of factors II, VII, IX and X and antithrombin III.
    Ruttyn Y; Brandin MP; Vijayalakshmi MA
    J Chromatogr; 1989 Jul; 491(2):299-308. PubMed ID: 2509508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of blood clotting factor activity in PPSB].
    Tarasova LN; Saltykova ZA
    Vopr Med Khim; 1974; 20(4):440-2. PubMed ID: 4462299
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prothrombin: a unit or complex?].
    Voss D
    Klin Wochenschr; 1967 May; 45(9):449-52. PubMed ID: 4967529
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.
    van Dieijen-Visser MP; van Wersch J; Brombacher PJ; Rosing J; Hemker HC; van Dieijen G
    Haemostasis; 1982; 12(3):241-55. PubMed ID: 7141303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration of hepatitis-B antigen from clinical preparations of II, VII, IX and X by polyethylene glycol, to enhance detection and removal.
    Johnson AJ
    Ann N Y Acad Sci; 1975 Jan; 240():162-4. PubMed ID: 234215
    [No Abstract]   [Full Text] [Related]  

  • 9. [Longitudinal study of factors X, IX, VIII, V, II and I in the first 6 months of life].
    Duvina PL; Simoni MR; Pezzati M; Poggi G; Rosati C; Trampi F; Duvina G
    Minerva Pediatr; 1987 May; 39(10):421-36. PubMed ID: 3116376
    [No Abstract]   [Full Text] [Related]  

  • 10. [Production of various vitamin K-dependent coagulation factors by immunoadsorbent technics and their clinical application].
    Takamiya O
    Rinsho Byori; 1985 Feb; Spec No 61():119-23. PubMed ID: 3889420
    [No Abstract]   [Full Text] [Related]  

  • 11. The purification of human factor II (prothrombin) and the preparation of a specific antiserum.
    Heystek J; Maier van den Zande GM; Brummelhuis HG; Krijnen HW
    Vox Sang; 1974; 27(3):214-26. PubMed ID: 4213473
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of ethanol feeding on the activities of factors II, VII, VIII, IX and X in rats.
    Morland J; Holm T; Prydz H
    Thromb Haemost; 1976 Dec; 36(3):532-6. PubMed ID: 1037150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural abnormalities of the vitamin K-dependent clotting factors.
    Roberts HR; Griffith MJ; Braunstein KM; Lundblad RL
    Prog Clin Biol Res; 1981; 72():85-102. PubMed ID: 7335651
    [No Abstract]   [Full Text] [Related]  

  • 14. A true hypercoagulability state in patients on chronic hemodialysis.
    Erickson RV; Williman M; Pendras JP
    Trans Am Soc Artif Intern Organs; 1966; 12():205-6. PubMed ID: 5960704
    [No Abstract]   [Full Text] [Related]  

  • 15. Coagulation in cephalhaematomas.
    Ströder J; Mingers AM
    Z Kinderheilkd; 1974; 116(4):153-61. PubMed ID: 4825915
    [No Abstract]   [Full Text] [Related]  

  • 16. Feeding of butylated hydroxytoluene to rats caused a rapid decrease in blood coagulation factors II (prothrombin), VII, IX and X.
    Takahashi O
    Arch Toxicol; 1986 Feb; 58(3):177-81. PubMed ID: 3964081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic use of fraction P.P.S.B.
    Soulier JP; Josso F; Steinbuch M; Cosson A
    Bibl Haematol; 1968; 29():1127-33. PubMed ID: 5700308
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vitamin K-dependent blood coagulation factors--structure, function and biosynthesis (author's transl)].
    Katayama K; Fujikawa K; Titani K
    Tanpakushitsu Kakusan Koso; 1979; 24(7):924-41. PubMed ID: 394189
    [No Abstract]   [Full Text] [Related]  

  • 19. Separation of vitamin K-dependent coagulation factors on sulphated cellulose.
    Benny AG; Ockelford PA; Brimer CM; Morgan AK
    J Chromatogr; 1989 Jan; 487(1):173-6. PubMed ID: 2715262
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential interaction of clotting factors II, VII, IX and X with sephadex and dextran blue.
    Swart AC; Kop-Klaassen BH; Hemker HC
    Haemostasis; 1972-1973; 1(5):237-52. PubMed ID: 4670119
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.